Thyroid Cancer and COVID-19: Prospects for Therapeutic Approaches and Drug Development

Thyroid cancer is the most prevalent endocrine malignancy and the reported incidence of thyroid cancer has continued to increase in recent years. Since 2019, coronavirus disease 2019 (COVID-19) has been spreading worldwide in a global pandemic. COVID-19 aggravates primary illnesses and affects disea...

Descripción completa

Detalles Bibliográficos
Autores principales: Qu, Na, Hui, Zongguang, Shen, Zhixin, Kan, Chengxia, Hou, Ningning, Sun, Xiaodong, Han, Fang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Endocrinology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9114699/
https://www.ncbi.nlm.nih.gov/pubmed/35600591
http://dx.doi.org/10.3389/fendo.2022.873027
_version_ 1784709837462962176
author Qu, Na
Hui, Zongguang
Shen, Zhixin
Kan, Chengxia
Hou, Ningning
Sun, Xiaodong
Han, Fang
author_facet Qu, Na
Hui, Zongguang
Shen, Zhixin
Kan, Chengxia
Hou, Ningning
Sun, Xiaodong
Han, Fang
author_sort Qu, Na
collection PubMed
description Thyroid cancer is the most prevalent endocrine malignancy and the reported incidence of thyroid cancer has continued to increase in recent years. Since 2019, coronavirus disease 2019 (COVID-19) has been spreading worldwide in a global pandemic. COVID-19 aggravates primary illnesses and affects disease management; relevant changes include delayed diagnosis and treatment. The thyroid is an endocrine organ that is susceptible to autoimmune attack; thus, thyroid cancer after COVID-19 has gradually attracted attention. Whether COVID-19 affects the diagnosis and treatment of thyroid cancer has also attracted the attention of many researchers. This review examines the literature regarding the influence of COVID-19 on the pathogenesis, diagnosis, and treatment of thyroid cancer; it also focuses on drug therapies to promote research into strategies for improving therapy and management in thyroid cancer patients with COVID-19.
format Online
Article
Text
id pubmed-9114699
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-91146992022-05-19 Thyroid Cancer and COVID-19: Prospects for Therapeutic Approaches and Drug Development Qu, Na Hui, Zongguang Shen, Zhixin Kan, Chengxia Hou, Ningning Sun, Xiaodong Han, Fang Front Endocrinol (Lausanne) Endocrinology Thyroid cancer is the most prevalent endocrine malignancy and the reported incidence of thyroid cancer has continued to increase in recent years. Since 2019, coronavirus disease 2019 (COVID-19) has been spreading worldwide in a global pandemic. COVID-19 aggravates primary illnesses and affects disease management; relevant changes include delayed diagnosis and treatment. The thyroid is an endocrine organ that is susceptible to autoimmune attack; thus, thyroid cancer after COVID-19 has gradually attracted attention. Whether COVID-19 affects the diagnosis and treatment of thyroid cancer has also attracted the attention of many researchers. This review examines the literature regarding the influence of COVID-19 on the pathogenesis, diagnosis, and treatment of thyroid cancer; it also focuses on drug therapies to promote research into strategies for improving therapy and management in thyroid cancer patients with COVID-19. Frontiers Media S.A. 2022-05-04 /pmc/articles/PMC9114699/ /pubmed/35600591 http://dx.doi.org/10.3389/fendo.2022.873027 Text en Copyright © 2022 Qu, Hui, Shen, Kan, Hou, Sun and Han https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Endocrinology
Qu, Na
Hui, Zongguang
Shen, Zhixin
Kan, Chengxia
Hou, Ningning
Sun, Xiaodong
Han, Fang
Thyroid Cancer and COVID-19: Prospects for Therapeutic Approaches and Drug Development
title Thyroid Cancer and COVID-19: Prospects for Therapeutic Approaches and Drug Development
title_full Thyroid Cancer and COVID-19: Prospects for Therapeutic Approaches and Drug Development
title_fullStr Thyroid Cancer and COVID-19: Prospects for Therapeutic Approaches and Drug Development
title_full_unstemmed Thyroid Cancer and COVID-19: Prospects for Therapeutic Approaches and Drug Development
title_short Thyroid Cancer and COVID-19: Prospects for Therapeutic Approaches and Drug Development
title_sort thyroid cancer and covid-19: prospects for therapeutic approaches and drug development
topic Endocrinology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9114699/
https://www.ncbi.nlm.nih.gov/pubmed/35600591
http://dx.doi.org/10.3389/fendo.2022.873027
work_keys_str_mv AT quna thyroidcancerandcovid19prospectsfortherapeuticapproachesanddrugdevelopment
AT huizongguang thyroidcancerandcovid19prospectsfortherapeuticapproachesanddrugdevelopment
AT shenzhixin thyroidcancerandcovid19prospectsfortherapeuticapproachesanddrugdevelopment
AT kanchengxia thyroidcancerandcovid19prospectsfortherapeuticapproachesanddrugdevelopment
AT houningning thyroidcancerandcovid19prospectsfortherapeuticapproachesanddrugdevelopment
AT sunxiaodong thyroidcancerandcovid19prospectsfortherapeuticapproachesanddrugdevelopment
AT hanfang thyroidcancerandcovid19prospectsfortherapeuticapproachesanddrugdevelopment

Ejemplares similares